For Immediate Release
PLEASANTON, Calif., July 16th, 2013—CooperVision, Inc., one of the world’s most respected soft contact lens manufacturers, today announced the appointment of Dr. Juan Carlos Aragon to the newly established role of senior vice president, Global Professional & Clinical Affairs, effective immediately
Dr. Aragon is now responsible for creating, implementing, and managing the company’s professional and clinical affairs strategy worldwide, reflecting CooperVision’s continued growth in developed and emerging markets.
As a qualified optometrist, Dr. Aragon has nearly three decades of experience in professional services, sales, marketing, general management and business development within the global ophthalmic industry. Since 2000, he has worked in various international roles within CooperVision, and most recently led the company’s Latin America commercial operations and Americas region business development initiatives. He previously held leadership roles with Ocular Sciences, CIBA Vision, and Bausch & Lomb.
Dr. Aragon also chairs the Global Development Board for Optometry Giving Sight, the nonprofit organization CooperVision supports as a Global Platinum Sponsor..
“I am enthusiastic about leading CooperVision’s global efforts to expand our presence among eye care communities, professional associations and academic institutions,” said Dr. Aragon. “Although we have always closely collaborated with eye care practitioners worldwide, this newly created role presents an opportunity to further strengthen and deepen those relationships.”
“We’re thrilled to add JC to our Global Strategy team, where his blend of international experience, practitioner knowledge and market insights will be of tremendous value,” said Andrew Sedgwick, CooperVision’s executive vice president of Commercial Strategy and Business Development.
Dr. Aragon is based at CooperVision headquarters in Pleasanton, California.
CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of frequent replacement and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges; such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, thereby creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. (“Cooper”) is a global medical device company publicly traded on the NYSE Euronext (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women’s health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 7,800 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.